An international team of clinical collaborators has performed the first-ever clinical test of the targeted therapy avapritinib in paediatric and young...

Glioma, the most common primary malignant tumour of the central nervous system, presents significant clinical challenges due to its pronounced...

London, UK -- 25 March 2025 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Blujepa...

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar. 26, 2025-- Exelixis, Inc. (Nasdaq: EXEL) today announced that the U.S. Food and Drug Administration (FDA) has...

A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Centre, USA, have uncovered a powerful...

A new study by Mayo Clinic Comprehensive Cancer Centre researchers found that the presence of a specific genetic mutation — KRAS circulating...

If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability accumulation in multiple...

If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability accumulation in multiple...

MONDAY, March 24, 2025 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for adult patients with moderately to severely...

The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable study results and...